Fibrosarcoma

15 registered clinical trials studyying Fibrosarcoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986	Fudan University	Phase 2
Not Yet Recruiting	Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk T NCT06526897	ECOG-ACRIN Cancer Research Group	N/A
Recruiting	Agnostic Therapy in Rare Solid Tumors NCT06638931	Instituto do Cancer do Estado de São Paulo	Phase 2
Recruiting	A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning NCT06387485	Ricoh USA, Inc.	N/A
Recruiting	MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154	HRYZ Biotech Co.	Phase 2
Unknown	Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas NCT03989596	Maria Sklodowska-Curie National Research Institute of Oncology	Phase 2
Unknown	Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Ex NCT03651375	Maria Sklodowska-Curie National Research Institute of Oncology	Phase 2
Completed	Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma NCT02584309	Washington University School of Medicine	Phase 2
Active Not Recruiting	Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867	National Cancer Institute (NCI)	Phase 2 / Phase 3
Completed	Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With NCT01962103	Celgene	Phase 1 / Phase 2
Completed	Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lun NCT00503295	Oncolytics Biotech	Phase 2
Completed	Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma NCT00400569	H. Lee Moffitt Cancer Center and Research Institute	Phase 2
Completed	Bevacizumab and Radiation Therapy for Sarcomas NCT00356031	Massachusetts General Hospital	Phase 2
Completed	Infantile Versus Adult-type Fibrosarcoma and the Risk of Multiple Primary Malignancies NCT06662734	asmaa salama ibrahim	—
Completed	Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers NCT00141765	University of Michigan Rogel Cancer Center	Phase 2